B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma
Objectivechordomas are rare bone tumors with few therapeutic options. Skull base and sacrum are the two most common origin sites. Immunotherapies are emerging as the most promising approaches to fight various cancers. This study tends to identify new cell surface targets for immunotherapeutic option...
Enregistré dans:
Auteurs principaux: | Cheng Long, Gaowei Li, Chengyun Zhang, Tao Jiang, Yanjun Li, Xin Duan, Gang Zhong |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5a57d5834a2c47fe85e1b1e834f5dd6c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma
par: Chubei Teng, et autres
Publié: (2021) -
Skull base chordomas review of current treatment paradigms
par: Dan Yaniv, et autres
Publié: (2020) -
Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy
par: Andreas Köthe, et autres
Publié: (2021) -
Gluteus maximus metastasis from sacrococcygeal chordoma: A case report
par: Wanchen Liu, MD, et autres
Publié: (2022) -
Microscopic and Endoscopic Transoral Approaches for the Management of Craniocervical Chordomas
par: Mohammad Fathy Eissa, et autres
Publié: (2021)